文献速递糖尿病

无糖尿病人群血浆鞘脂与血糖及葡萄糖耐量的关系

Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

研究纳入240名多种族队列参与者和280名糖尿病预防计划参与者,用液相色谱串联质谱检测血浆鞘脂。空腹和2小时血糖与神经酰胺、鞘磷脂、鞘氨醇正相关,与单己糖基神经酰胺、乳糖基神经酰胺、1-磷酸鞘氨醇负相关;不同糖耐量分组间鞘脂呈梯度变化。

要点

  • 空腹和2小时血糖与神经酰胺、鞘磷脂、鞘氨醇水平正相关。
  • 空腹和2小时血糖与单己糖基神经酰胺、乳糖基神经酰胺、1-磷酸鞘氨醇负相关。
  • 从血糖正常到单纯糖耐量受损再到空腹血糖受损合并糖耐量受损,神经酰胺等递增而单己糖基神经酰胺等递减。

核心结论

  • 循环中主要鞘脂种类与血糖和葡萄糖耐量显著相关,提示无糖尿病人群中鞘脂代谢与血糖调控可能存在关联。

研究设计与样本

  • 研究检测了「多种族队列中糖尿病前期病理生物学研究」240名参与者和「糖尿病预防计划」280名参与者的基线血浆鞘脂。
  • 研究对象为无糖尿病的成人,根据口服葡萄糖耐量试验分为血糖正常、单纯空腹血糖受损、单纯糖耐量受损、空腹血糖受损合并糖耐量受损四组。
  • 血浆鞘脂种类包括神经酰胺、单己糖基神经酰胺、乳糖基神经酰胺、鞘磷脂和鞘氨醇,采用液相色谱串联质谱法检测。

主要发现

  • 参与者平均年龄45.5±9.84岁,体重指数32.4±7.24 kg/m²,空腹血糖99.8±10.5 mg/dL,2小时血糖145±29.4 mg/dL。
  • 校正年龄、性别、种族和体重指数后,空腹血糖和2小时血糖与神经酰胺、鞘磷脂和鞘氨醇水平呈正相关。
  • 校正年龄、性别、种族和体重指数后,空腹血糖和2小时血糖与单己糖基神经酰胺、乳糖基神经酰胺和1-磷酸鞘氨醇水平呈负相关。
  • 血浆神经酰胺、鞘磷脂和鞘氨醇在血糖正常、单纯糖耐量受损、空腹血糖受损合并糖耐量受损参与者中递增,而单己糖基神经酰胺、乳糖基神经酰胺和1-磷酸鞘氨醇呈相反变化(方差分析P<.0001)。

关键数值与推荐

  • 空腹血糖正常定义为<100 mg/dL,且2小时血浆葡萄糖<140 mg/dL为糖耐量正常。
  • 空腹血糖受损定义为100-125 mg/dL且2小时血浆葡萄糖正常。
  • 糖耐量受损定义为2小时血浆葡萄糖140-199 mg/dL且空腹血糖正常。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Sphingolipids have been linked to the pathogenesis of type 2 diabetes. OBJECTIVE: To examine the association of plasma sphingolipids with glycemic measures in adults without diabetes. METHODS: Plasma sphingolipid species (ceramides, monohexosyl ceramides, lactosyl ceramides, sphingomyelins, and sphingosines) were assayed using liquid chromatography tandem mass spectrometry in baseline specimens obtained from participants in the Pathobiology of Prediabetes in a Biracial Cohort study (n = 240) and the Diabetes Prevention Program (n = 280). Based on oral glucose tolerance tests, we identified participants with (1) normal fasting plasma glucose (NFG) (<100 mg/dL) and normal glucose tolerance (NGT) [2-hour plasma glucose (2hPG) < 140 mg/dL]; (2) impaired fasting glucose (IFG; 100-125 mg/dL) with normal 2hPG; (3) impaired glucose tolerance (IGT) (2hPG 140-199 mg/dL with NFG); and (4) IFG and IGT. RESULTS: The participants (63% female; 48% Black, 52% White) had a mean age of 45.5 ± 9.84 years, body mass index (BMI) 32.4 ± 7.24 kg/m2, fasting plasma glucose (FPG) 99.8 ± 10.5 mg/dL, and 2hPG 145 ± 29.4 mg/dL. FPG and 2hPG levels correlated positively with ceramides, sphingomyelins, and sphingosine and inversely with monohexosyl ceramides, lactosyl ceramides, and sphingosine-1 phosphate levels, adjusted for age, sex, race, and BMI. Plasma ceramides, sphingomyelins, and sphingosine increased progressively across participants with NFG-NGT, isolated IGT, and IFG-IGT, whereas the opposite was seen for monohexosyl ceramides, lactosyl ceramides, and sphingosine-1 phosphate levels (ANOVA P < .0001). CONCLUSION: Circulating levels of major sphingolipid species are significantly associated with glycemia and glucose tolerance, indicating a possible link between sphingolipid metabolism and glucoregulation in people without diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Asuzu P, Aliye N, Stentz F, et al. Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes. J Clin Endocrinol Metab. 2026. PMID: 40570250. doi:10.1210/clinem/dgaf378

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。